The Navilas® micropulse laser can be used to treat patients with macular edema and good visual acuity, which therefore do not fall within the indications for conventional treatments by intravitreal injections. The CHU Brugmann Hospital is the only center to own this laser in Belgium.This study aims to evaluate the efficacy of this laser.
Study Type
OBSERVATIONAL
Enrollment
23
Data extraction from medical files
CHU Brugmann
Brussels, Belgium
Visual acuity
Time frame: Baseline versus three months after treatment
Retinal thickness change
Time frame: Baseline versus three months after treatment
Periodicity of anti-VEGF injections
Time frame: Baseline versus three months after treatment
Scar - assessed by optical coherence tomography
Time frame: Three months after treatment
Scar - assessed by fluorescein angiography
Time frame: Three months after treatment
Scar - assessed by auto-fluorescence fundus images
Time frame: Three months after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.